Visual Evoked Potential as surrogate for remyelination

As we enter the era of trying to remyelinate our CNS with therapies yet to be developed, the question still remains - how will we know they are working? Currently, imaging technologies are not able to show myelin precisely enough to know if a therapy was working or not.

This study concludes that certain VEP tests can be used as surrogate outcome measure for remyelination trials.